2023 Q3 Form 10-Q Financial Statement

#000121390023063656 Filed on August 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2022 Q3
Revenue $387.1M $354.1M
YoY Change 9.33% 126.68%
Cost Of Revenue $219.2M $212.9M
YoY Change 2.95% 130.36%
Gross Profit $167.9M $141.2M
YoY Change 18.95% 121.34%
Gross Profit Margin 43.37% 39.86%
Selling, General & Admin $64.70M $55.83M
YoY Change 15.89% 78.87%
% of Gross Profit 38.53% 39.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $29.70M $28.64M
YoY Change 3.69% 248.78%
% of Gross Profit 17.69% 20.29%
Operating Expenses $64.70M $55.83M
YoY Change 15.89% 78.87%
Operating Profit $85.00M $64.47M
YoY Change 31.84% 119.94%
Interest Expense $20.50M $15.80M
YoY Change 29.76% 4852.66%
% of Operating Profit 24.12% 24.51%
Other Income/Expense, Net -$500.0K -$767.0K
YoY Change -34.81% -264.95%
Pretax Income $64.00M $47.90M
YoY Change 33.6% 62.61%
Income Tax $14.00M $10.47M
% Of Pretax Income 21.88% 21.85%
Net Earnings $50.00M $37.44M
YoY Change 33.55% 55.75%
Net Earnings / Revenue 12.92% 10.57%
Basic Earnings Per Share $1.53 $1.11
Diluted Earnings Per Share $1.52 $1.09
COMMON SHARES
Basic Shares Outstanding 28.85M shares 28.67M shares
Diluted Shares Outstanding 29.11M shares 28.94M shares

Balance Sheet

Concept 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $56.70M $119.6M
YoY Change -52.59% -59.61%
Cash & Equivalents $56.70M $119.6M
Short-Term Investments
Other Short-Term Assets $18.40M $14.58M
YoY Change 26.19% 77.23%
Inventory $603.3M $542.1M
Prepaid Expenses
Receivables $251.8M $235.0M
Other Receivables $0.00 $0.00
Total Short-Term Assets $935.5M $916.1M
YoY Change 2.12% 16.53%
LONG-TERM ASSETS
Property, Plant & Equipment $370.5M $384.5M
YoY Change -3.64% 59.58%
Goodwill $1.871B $1.877B
YoY Change -0.31%
Intangibles $1.436B $1.501B
YoY Change -4.32%
Long-Term Investments
YoY Change
Other Assets $42.50M $35.98M
YoY Change 18.12% 13.0%
Total Long-Term Assets $3.762B $3.842B
YoY Change -2.08% 445.36%
TOTAL ASSETS
Total Short-Term Assets $935.5M $916.1M
Total Long-Term Assets $3.762B $3.842B
Total Assets $4.697B $4.758B
YoY Change -1.27% 219.2%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $140.0M $161.8M
YoY Change -13.49% 279.12%
Accrued Expenses $40.20M $38.78M
YoY Change 3.66% 2.9%
Deferred Revenue $20.40M $21.01M
YoY Change -2.9%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.600M $1.525M
YoY Change 4.92% 201.98%
Total Short-Term Liabilities $316.0M $330.4M
YoY Change -4.36% 245.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.343B $1.564B
YoY Change -14.1% 15158.12%
Other Long-Term Liabilities $123.0M $118.6M
YoY Change 3.68% 28.24%
Total Long-Term Liabilities $1.466B $1.682B
YoY Change -12.85% 1537.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $316.0M $330.4M
Total Long-Term Liabilities $1.466B $1.682B
Total Liabilities $2.110B $2.360B
YoY Change -10.62% 991.64%
SHAREHOLDERS EQUITY
Retained Earnings $1.074B $917.8M
YoY Change 17.04%
Common Stock $300.0K $299.0K
YoY Change 0.33%
Preferred Stock
YoY Change
Treasury Stock (at cost) $86.90M $78.34M
YoY Change 10.93%
Treasury Stock Shares 958.8K shares
Shareholders Equity $2.588B $2.398B
YoY Change
Total Liabilities & Shareholders Equity $4.697B $4.758B
YoY Change -1.27% 219.2%

Cashflow Statement

Concept 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income $50.00M $37.44M
YoY Change 33.55% 55.75%
Depreciation, Depletion And Amortization $29.70M $28.64M
YoY Change 3.69% 248.78%
Cash From Operating Activities $61.70M $59.04M
YoY Change 4.51% 10.77%
INVESTING ACTIVITIES
Capital Expenditures $6.700M $7.857M
YoY Change -14.73% 133.35%
Acquisitions -$22.97M
YoY Change
Other Investing Activities $200.0K $23.01M
YoY Change -99.13% -176.85%
Cash From Investing Activities -$6.500M $15.16M
YoY Change -142.89% -145.5%
FINANCING ACTIVITIES
Cash Dividend Paid $5.800M
YoY Change
Common Stock Issuance & Retirement, Net $6.800M $5.984M
YoY Change 13.64% -4.47%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$63.60M -$136.4M
YoY Change -53.36% -3106.22%
NET CHANGE
Cash From Operating Activities $61.70M $59.04M
Cash From Investing Activities -$6.500M $15.16M
Cash From Financing Activities -$63.60M -$136.4M
Net Change In Cash -$8.700M -$63.28M
YoY Change -86.25% -356.33%
FREE CASH FLOW
Cash From Operating Activities $61.70M $59.04M
Capital Expenditures $6.700M $7.857M
Free Cash Flow $55.00M $51.18M
YoY Change 7.47% 2.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2023Q3 dei Document Type
DocumentType
10-Q
CY2023Q3 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q3 dei Document Period End Date
DocumentPeriodEndDate
2023-07-01
CY2023Q3 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q3 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q3 dei Entity File Number
EntityFileNumber
001-40840
CY2023Q3 dei Entity Registrant Name
EntityRegistrantName
RBC BEARINGS INCORPORATED
CY2023Q3 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q3 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
95-4372080
CY2023Q3 dei Entity Address Address Line1
EntityAddressAddressLine1
One Tribology Center
CY2023Q3 dei Entity Address City Or Town
EntityAddressCityOrTown
Oxford
CY2023Q3 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2023Q3 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06478
CY2023Q3 dei City Area Code
CityAreaCode
(203)
CY2023Q3 dei Local Phone Number
LocalPhoneNumber
267-7001
CY2023Q3 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q3 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q3 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q3 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q3 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q3 dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
29056110 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
56700000 usd
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65400000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000000 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
3700000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
251800000 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
239600000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
603300000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
587200000 usd
CY2023Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
23700000 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
21100000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
935500000 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
913300000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
370500000 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
375300000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
42100000 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
41400000 usd
CY2023Q3 us-gaap Goodwill
Goodwill
1870900000 usd
CY2023Q2 us-gaap Goodwill
Goodwill
1869800000 usd
CY2023Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1435900000 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1452900000 usd
CY2023Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
42500000 usd
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37700000 usd
CY2023Q3 us-gaap Assets
Assets
4697400000 usd
CY2023Q2 us-gaap Assets
Assets
4690400000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
140000000 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
146800000 usd
CY2023Q3 roll Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
166800000 usd
CY2023Q2 roll Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
153400000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7600000 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7600000 usd
CY2023Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
1600000 usd
CY2023Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
1500000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
316000000 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
309300000 usd
CY2023Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1343300000 usd
CY2023Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1393500000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
34900000 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
33900000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
292500000 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
295100000 usd
CY2023Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
123000000 usd
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
122700000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
2109700000 usd
CY2023Q2 us-gaap Liabilities
Liabilities
2154500000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4600000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
4600000 shares
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30056347 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29989948 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
300000 usd
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
300000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1595800000 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1589900000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4300000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4100000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1074200000 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1029900000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
999202 shares
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
966398 shares
CY2023Q3 us-gaap Treasury Stock Value
TreasuryStockValue
86900000 usd
CY2023Q2 us-gaap Treasury Stock Value
TreasuryStockValue
80100000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2587700000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2535900000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4697400000 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4690400000 usd
CY2023Q3 us-gaap Revenues
Revenues
387100000 usd
CY2022Q3 us-gaap Revenues
Revenues
354100000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
219200000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
212900000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
167900000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
141200000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64700000 usd
CY2022Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55800000 usd
CY2023Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
18200000 usd
CY2022Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
20900000 usd
CY2023Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
82900000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
76700000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
85000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
64500000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
20500000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
15800000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-500000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-800000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
64000000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47900000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
14000000 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10500000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
37400000 usd
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
28600000 usd
CY2023Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-2600000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5700000 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5700000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44300000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
31700000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28846874 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28670488 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29114819 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28944955 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
37400000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4800000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3100000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-6400000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
58400000 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
31500000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2535900000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50000000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
4900000 usd
CY2023Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
5700000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6800000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000000 usd
CY2023Q3 roll Net Of Tax Expense
NetOfTaxExpense
200000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Plan Amendments Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansPlanAmendmentsTaxEffect
500000 usd
CY2023Q3 us-gaap Discontinued Operation Tax Effect Of Income Loss From Discontinued Operation During Phase Out Period
DiscontinuedOperationTaxEffectOfIncomeLossFromDiscontinuedOperationDuringPhaseOutPeriod
1400000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4800000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
3100000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2587700000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
2372500000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
37400000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3800000 usd
CY2022Q3 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
5700000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6000000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1500000 usd
CY2022Q3 roll Net Of Tax Expense
NetOfTaxExpense
200000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Plan Amendments Tax Effect
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansPlanAmendmentsTaxEffect
500000 usd
CY2022Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-6400000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
2397600000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
37400000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
29700000 usd
CY2022Q3 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4100000 usd
CY2023Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
900000 usd
CY2022Q3 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2300000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
5400000 usd
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
3800000 usd
CY2023Q3 us-gaap Noncash Contribution Expense
NoncashContributionExpense
1700000 usd
CY2022Q3 us-gaap Noncash Contribution Expense
NoncashContributionExpense
1700000 usd
CY2023Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-200000 usd
CY2022Q3 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0 usd
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
300000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
12000000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11400000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
15600000 usd
CY2022Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
28200000 usd
CY2023Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2100000 usd
CY2022Q3 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2800000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2600000 usd
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
4300000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-6800000 usd
CY2022Q3 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3700000 usd
CY2023Q3 roll Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
13000000 usd
CY2022Q3 roll Increase Decrease In Accrued Expenses And Other Current Liabilities
IncreaseDecreaseInAccruedExpensesAndOtherCurrentLiabilities
13300000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2200000 usd
CY2022Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3800000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
61700000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
59000000 usd
CY2023Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
6700000 usd
CY2022Q3 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
7900000 usd
CY2023Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
200000 usd
CY2022Q3 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
100000 usd
CY2022Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-23000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6500000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
15200000 usd
CY2023Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
50000000 usd
CY2022Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
125000000 usd
CY2023Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1100000 usd
CY2022Q3 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
100000 usd
CY2023Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1000000 usd
CY2022Q3 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
1100000 usd
CY2023Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5700000 usd
CY2022Q3 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5700000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000000 usd
CY2022Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1500000 usd
CY2023Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6800000 usd
CY2022Q3 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6000000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-63600000 usd
CY2022Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-136400000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-300000 usd
CY2022Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1100000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8700000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-63300000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65400000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
182900000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
56700000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
119600000 usd
CY2023Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
1100000 usd
CY2022Q3 us-gaap Income Taxes Paid
IncomeTaxesPaid
900000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
25100000 usd
CY2022Q3 us-gaap Interest Paid Net
InterestPaidNet
19300000 usd
CY2023Q3 us-gaap Revenues
Revenues
387100000 usd
CY2022Q3 us-gaap Revenues
Revenues
354100000 usd
CY2023Q3 us-gaap Revenues
Revenues
387100000 usd
CY2022Q3 us-gaap Revenues
Revenues
354100000 usd
CY2023Q3 roll Revenue Performance Obligation Percentage
RevenuePerformanceObligationPercentage
1 pure
CY2022Q3 roll Revenue Performance Obligation Percentage
RevenuePerformanceObligationPercentage
1 pure
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
413400000 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Explanation
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionExplanation
The Company expects to recognize revenue on approximately 63% and 90% of the remaining performance obligations over the next 12 and 24 months, respectively, with the remainder recognized thereafter.
CY2023Q3 roll Contract Asset Current
ContractAssetCurrent
5300000 usd
CY2023Q2 roll Contract Asset Current
ContractAssetCurrent
4500000 usd
CY2023Q3 roll Contract Liability Current
ContractLiabilityCurrent
23100000 usd
CY2022Q2 roll Contract Liability Current
ContractLiabilityCurrent
20600000 usd
CY2023Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4600000 usd
CY2022Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3900000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40200000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39600000 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4100000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
3100000 usd
CY2023Q3 us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
5300000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
8400000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
4300000 usd
CY2023Q3 us-gaap Debt Conversion Converted Instrument Rate
DebtConversionConvertedInstrumentRate
0.05 pure
CY2023Q3 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
4600000 shares
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
50000000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
37400000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5700000 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
5700000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
44300000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
31700000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28846874 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28670488 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
267945 shares
CY2022Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
274467 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29114819 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28944955 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.53
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.52
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2023Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
448000000 usd
CY2023Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
450000000 usd
CY2023Q3 roll Debt Non Current
DebtNonCurrent
493500000 usd
CY2023Q2 roll Debt Non Current
DebtNonCurrent
493300000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
131600000 usd
CY2023Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
132400000 usd
CY2023Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
141700000 usd
CY2023Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
132500000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
330000000 usd
CY2023Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
322300000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
603300000 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
587200000 usd
CY2023Q2 us-gaap Goodwill Gross
GoodwillGross
1869800000 usd
CY2023Q3 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1100000 usd
CY2023Q3 us-gaap Goodwill Gross
GoodwillGross
1870900000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1590400000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
178800000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1589900000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
161300000 usd
CY2023Q3 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
24300000 usd
CY2023 us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
24300000 usd
CY2023 roll Finite Lived Intangible Asset Useful Life Total
FiniteLivedIntangibleAssetUsefulLifeTotal
P24Y
CY2023Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1614700000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
178800000 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1614200000 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
161300000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17500000 usd
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17300000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
53000000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
70500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
67700000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
65900000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
63600000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
63600000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1027300000 usd
CY2023Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33400000 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
34700000 usd
CY2023Q3 roll Taxes Current
TaxesCurrent
34500000 usd
CY2023Q2 roll Taxes Current
TaxesCurrent
17500000 usd
CY2023Q3 roll Contracts Liabilities
ContractsLiabilities
23100000 usd
CY2023Q2 roll Contracts Liabilities
ContractsLiabilities
20600000 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
40200000 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39600000 usd
CY2023Q3 roll Current Finance Lease Liabilitie
CurrentFinanceLeaseLiabilitie
5300000 usd
CY2023Q2 roll Current Finance Lease Liabilitie
CurrentFinanceLeaseLiabilitie
5200000 usd
CY2023Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
4900000 usd
CY2023Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
4900000 usd
CY2023Q3 us-gaap Interest Payable Current
InterestPayableCurrent
5100000 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
10600000 usd
CY2023Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7600000 usd
CY2023Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7500000 usd
CY2023Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12700000 usd
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12800000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
166800000 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
153400000 usd
CY2023Q3 us-gaap Line Of Credit Facility Commitment Fee Percentage
LineOfCreditFacilityCommitmentFeePercentage
0.002 pure
CY2023Q3 roll Letter Of Credit Fee Rate
LetterOfCreditFeeRate
0.0125 pure
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearThree
0 usd
CY2023Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
850000000 usd
CY2023Q3 us-gaap Line Of Credit Facility Covenant Terms
LineOfCreditFacilityCovenantTerms
The Credit Agreement requires the Company to comply with various covenants, including the following financial covenants: (a) a maximum Total Net Leverage Ratio (as defined within the Credit Agreement) of 5.00:1.00, which maximum Total Net Leverage Ratio shall decrease during certain subsequent test periods as set forth in the Credit Agreement (provided that, no more than once during the term of the Facilities, such maximum ratio applicable at such time may be increased by the Company by 0.50:1.00 for a period of twelve (12) months after the consummation of a material acquisition); and (b) a minimum Interest Coverage Ratio of 2.00:1.00.
CY2023Q3 roll Outstanding Amounts Still Owed Under The Term Loan Facility
OutstandingAmountsStillOwedUnderTheTermLoanFacility
850000000 usd
CY2023Q3 roll Revolving Credit Facility Borrowing Capacity
RevolvingCreditFacilityBorrowingCapacity
496300000 usd
CY2021Q4 us-gaap Proceeds From Issuance Of Senior Long Term Debt
ProceedsFromIssuanceOfSeniorLongTermDebt
492000000 usd
CY2023Q3 roll Debt Instrument Interest Rate
DebtInstrumentInterestRate
0.04375 pure
CY2023Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2029-10-15
CY2023Q3 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
100000 usd
CY2023Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
850000000 usd
CY2023Q2 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
900000000 usd
CY2023Q3 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2023Q2 us-gaap Senior Notes
SeniorNotes
500000000 usd
CY2023Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
12900000 usd
CY2023Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
13700000 usd
CY2023Q3 us-gaap Other Long Term Debt
OtherLongTermDebt
7800000 usd
CY2023Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
8700000 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1344900000 usd
CY2023Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1395000000 usd
CY2023Q3 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
1600000 usd
CY2023Q2 us-gaap Other Long Term Debt Current
OtherLongTermDebtCurrent
1500000 usd
CY2023Q3 us-gaap Long Term Debt
LongTermDebt
1343300000 usd
CY2023Q2 us-gaap Long Term Debt
LongTermDebt
1393500000 usd
CY2022Q4 us-gaap Derivative Remaining Maturity1
DerivativeRemainingMaturity1
P3Y
CY2022Q4 us-gaap Derivative Fixed Interest Rate
DerivativeFixedInterestRate
0.04455 pure
CY2023Q3 roll Specified Time Period
SpecifiedTimePeriod
P3Y
CY2023Q3 roll Other Comprehensive Income Derivative Component
OtherComprehensiveIncomeDerivativeComponent
2600000 usd
CY2022Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.219 pure
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
400000 usd
CY2023Q3 us-gaap Effective Income Tax Rate Reconciliation Other Reconciling Items Percent
EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent
0.226 pure
CY2022Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
600000 usd
CY2022Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
100000 usd
CY2023Q3 us-gaap Revenues
Revenues
387100000 usd
CY2022Q3 us-gaap Revenues
Revenues
354100000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
167900000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
141200000 usd
CY2023Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
64700000 usd
CY2022Q3 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
55800000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
85000000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
64500000 usd
CY2023Q3 us-gaap Assets
Assets
4697400000 usd
CY2023Q2 us-gaap Assets
Assets
4690400000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
usd
CY2022Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
usd
CY2023Q3 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
usd
CY2023 roll Nonamortizable Repair Station Certifications
NonamortizableRepairStationCertifications
CY2023Q3 roll Accumulated Amortization Of Nonamortizable Repair Station Certification
AccumulatedAmortizationOfNonamortizableRepairStationCertification
usd
CY2023Q2 roll Accumulated Amortization Of Nonamortizable Repair Station Certification
AccumulatedAmortizationOfNonamortizableRepairStationCertification
usd
CY2023Q3 dei Amendment Flag
AmendmentFlag
false
CY2023Q3 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--03-30
CY2023Q3 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q3 dei Entity Central Index Key
EntityCentralIndexKey
0001324948

Files In Submission

Name View Source Status
0001213900-23-063656-index-headers.html Edgar Link pending
0001213900-23-063656-index.html Edgar Link pending
0001213900-23-063656.txt Edgar Link pending
0001213900-23-063656-xbrl.zip Edgar Link pending
f10q0723ex31-01_rbcbearings.htm Edgar Link pending
f10q0723ex31-02_rbcbearings.htm Edgar Link pending
f10q0723ex32-01_rbcbearings.htm Edgar Link pending
f10q0723ex32-02_rbcbearings.htm Edgar Link pending
f10q0723_rbcbearings.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
f10q0723_rbcbearings_htm.xml Edgar Link completed
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
roll-20230701.xsd Edgar Link pending
Show.js Edgar Link pending
roll-20230701_def.xml Edgar Link unprocessable
roll-20230701_lab.xml Edgar Link unprocessable
roll-20230701_pre.xml Edgar Link unprocessable
roll-20230701_cal.xml Edgar Link unprocessable